Review article: alternative approaches to the long-term management of GERD
- 1 December 2005
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 22 (s3) , 39-44
- https://doi.org/10.1111/j.1365-2036.2005.02711.x
Abstract
Although proton-pump inhibitors are highly effective for the treatment of gastro-oesophageal reflux disease, there are issues with long-term maintenance therapy: not all patients require full daily dose for maintenance treatment, some patients are reluctant to take long-term daily medication, and long-term PPI therapy is inadequate for some patients. This article aims to review alternatives to daily proton-pump inhibitor therapy for the long-term management of gastro-oesophageal reflux disease, including intermittent or on-demand proton-pump inhibitor use, as well as endoscopic and surgical options. On-demand proton-pump inhibitor therapy has demonstrated efficacy in achieving acceptable symptom control, healing and maintenance of quality of life for a proportion of patients with gastro-oesophageal reflux disease. Endoscopic antireflux procedures can reduce the need for proton-pump inhibitor therapy, but safety and durability of these procedures require more study. Surgical treatment of gastro-oesophageal reflux disease in properly selected patients has demonstrated efficacy in reducing symptoms and the need for proton-pump inhibitor therapy; however, long-term follow-up suggests that it is not a permanent solution for many patients. While daily proton-pump inhibitor therapy remains the main treatment regimen option for most patients with gastro-oesophageal reflux disease, on-demand therapy may prove effective for many patients. Endoscopic anti-reflux therapies and surgery are options for patients who prefer nonpharmacological treatment, but experience is limited at this point in time for the former.Keywords
This publication has 22 references indexed in Scilit:
- Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 monthsGastrointestinal Endoscopy, 2005
- PPI use in the OTC era: Who to treat, with what, and for how long?Clinical Gastroenterology and Hepatology, 2005
- Systematic review: is there excessive use of proton pump inhibitors in gastro‐oesophageal reflux disease?Alimentary Pharmacology & Therapeutics, 2004
- Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux diseaseAlimentary Pharmacology & Therapeutics, 2004
- Endoscopic Gastric Plication (EndoCinch) for GERD: A Randomized, Sham-Controlled, Blinded, Single-Center StudyGastrointestinal Endoscopy, 2004
- The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trialGastrointestinal Endoscopy, 2002
- Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux DiseaseJAMA, 2001
- Transoral, flexible endoscopic suturing for treatment of GERD: A multicenter trialGastrointestinal Endoscopy, 2001
- Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux diseaseJournal of the American College of Surgeons, 2001
- Comparison of Medical and Surgical Therapy for Complicated Gastroesophageal Reflux Disease in VeteransNew England Journal of Medicine, 1992